How many shares of PCRX does GEODE CAPITAL MANAGEMENT, LLC own?

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC holds 1.2M shares of PCRX (PACIRA BIOSCIENCES INC).

What is GEODE CAPITAL MANAGEMENT, LLC's PCRX position worth?

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC's PCRX position is worth $29.4M.

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling PCRX?

In 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC increased their PCRX position (+1.3% change in shares).

When did GEODE CAPITAL MANAGEMENT, LLC first buy PCRX?

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in PCRX in 2018-Q4. They have held the position across 31 quarters.

Back to

GEODE CAPITAL MANAGEMENT, LLC

PCRX
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLC's holdings in PACIRA BIOSCIENCES INC

Current Value

$29.4M

Current Shares

1.2M

Total Value Change

-$15.1M

Total Shares Change

+125,145

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.2M	+1.3%	$29.4M	0.0%	$25.37	29
2026-Q1	Decreased	1.1M	-2.2%	$25.9M	0.0%	$22.10	0
2025-Q4	Decreased	1.2M	-3.8%	$30.3M	0.0%	$26.07	0
2025-Q3	Increased	1.2M	+6.4%	$31.3M	0.0%	$25.34	31
2025-Q2	Increased	1.1M	+0.5%	$27.3M	0.0%	$23.48	29
2025-Q1	Increased	1.1M	+4.2%	$28.3M	0.0%	$24.91	30
2024-Q4	Increased	1.1M	+0.5%	$20.6M	0.0%	$18.94	28
2024-Q3	Decreased	1.1M	-0.2%	$16.4M	0.0%	$14.54	0
2024-Q2	Increased	1.1M	+5.1%	$31.2M	0.0%	$28.61	30
2024-Q1	Increased	1M	+3.3%	$30.3M	0.0%	$29.22	30
2023-Q4	Increased	1M	+4.9%	$33.9M	0.0%	$33.74	30
2023-Q3	Increased	956,377	+4.0%	$29.3M	0.0%	$30.68	30
2023-Q2	Increased	919,601	+4.2%	$36.8M	0.0%	$39.51	30
2023-Q1	Increased	882,784	+4.3%	$36M	0.0%	$40.18	30
2022-Q4	Increased	846,163	+3.3%	$32.7M	0.0%	$38.61	30
2022-Q3	Increased	819,330	+2.8%	$43.6M	0.0%	$54.24	30
2022-Q2	Increased	797,153	+0.8%	$46.5M	0.0%	$58.63	29
2022-Q1	Decreased	790,812	-5.5%	$60.4M	0.0%	$75.67	0
2021-Q4	Increased	837,133	+1.0%	$50.4M	0.0%	$60.89	30
2021-Q3	Increased	828,649	+0.1%	$46.4M	0.0%	$56.72	29
2021-Q2	Increased	827,427	+4.3%	$50.2M	0.0%	$60.68	31
2021-Q1	Increased	793,062	+6.8%	$55.6M	0.0%	$70.82	31
2020-Q4	Increased	742,842	+7.5%	$44.5M	0.0%	$58.71	31
2020-Q3	Decreased	690,736	-2.0%	$41.5M	0.0%	$59.39	0
2020-Q2	Increased	704,562	+4.8%	$37M	0.0%	$52.02	30
2020-Q1	Decreased	672,083	-47.5%	$22.5M	0.0%	$33.71	0
2019-Q4	Increased	1.3M	+106.5%	$58M	0.0%	$44.36	47
2019-Q3	Increased	619,616	+1.1%	$23.6M	0.0%	$40.00	29
2019-Q2	Increased	612,820	+11.7%	$26.7M	0.0%	$43.49	32
2019-Q1	Decreased	548,824	-46.9%	$20.9M	0.0%	$38.06	0
2018-Q4	New	1M	-	$44.5M	0.0%	$42.51	40

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

PCRX31 quarters

PCRX
31 quarters